Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Business share repurchase

Novo Nordisk share repurchase programme

Analysis based on 41 articles · First reported May 26, 2026 · Last updated Jul 13, 2026

Sentiment
10
Attention
1
Articles
41
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The share repurchase programme signals Novo Nordisk's confidence in its financial health and may support the stock price by reducing supply. The ongoing buyback is a routine capital allocation activity with modest market impact.

pharmaceutical

Novo Nordisk is executing a share repurchase programme of up to DKK 15 billion over 12 months starting 4 February 2026. Under a sub-programme initiated 6 May 2026, the company repurchases B shares for up to DKK 11.2 billion through 1 February 2027. As of 26 June 2026, Novo Nordisk has repurchased 22,009,179 B shares at an average price of DKK 268.02 per share, totaling DKK 5.9 billion. The company holds 39,194,480 B shares as treasury shares, representing 0.9% of share capital. The programme is conducted under EU Safe Harbour Rules.

90 Novo Nordisk initiated share repurchase
stock
Novo Nordisk is executing the share repurchase programme, repurchasing its own B shares as part of a DKK 15 billion buyback plan.
Importance 100.0 Sentiment 10.0
exch
Novo Nordisk's B shares are listed on Nasdaq Copenhagen, where the repurchases are executed.
Importance 10.0 Sentiment 0.0
alliance
The share repurchase program adheres to regulations set by the Council of the European Union, demonstrating compliance with European financial frameworks.
Importance 5.0 Sentiment 0.0
govactor
The share repurchase program is conducted in accordance with regulations from the European Union — European Parliament and Council, ensuring compliance with European financial laws.
Importance 5.0 Sentiment 0.0
curr
The repurchase programme is denominated in Denmark — Danish kroner, with transactions reported in DKK.
Importance 5.0 Sentiment 0.0
exch
Novo Nordisk's ADRs are listed on the New York Stock Exchange, but the repurchase programme involves B shares traded on Nasdaq Copenhagen.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.